trending Market Intelligence /marketintelligence/en/news-insights/trending/h-kwzmcrsmh4oleycz1lsa2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Aurinia closes $28.8M bought-deal offering

Brazil Pay TV Down Record Amount In 2019, With Losses Continuing In Q1'20

Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm

Impact of COVID 19 on US Video Entertainment Trends

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19


Aurinia closes $28.8M bought-deal offering

Aurinia Pharmaceuticals Inc. closed its $28.8 million bought-deal offering, which included $3.8 million pursuant to an exercise of the underwriter's overallotment option, for the sale of 12,777,775 units at $2.25 per unit.

Each unit consists of one common share and one-half of one common share purchase warrant. Each warrant will be exercisable into one share for $3 apiece for a period of 5 years after the offering closes.

H.C. Wainwright & Co. LLC was sole book-running manager and Cormark Securities Inc. was co-manager for the offering.